Some patients become advocates because everything went right: the diagnosis was made early, the surgery went well, the cancer-driving mutation was found and communicated to other family members, ...

Martei is a medical oncologist, cancer outcomes researcher, and an assistant professor of medicine at the University of Pennsylvania. As a medical oncologist, one of the first threats I inform new ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

Functional characteristics, applications, and limitations of patient-derived tumor organoids in cancer modeling and therapeutic discovery. This figure illustrates the central role of tumor organoids ...